1,894 results on '"Arthritis, Juvenile"'
Search Results
2. A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants (TRILOGY)
3. Chronic Non-inflammatory Pains in Rheumatopediatrics (RHUMEDOL)
4. Exercise Programs on Gait in Children JIA
5. M3-JIA: Making Mindfulness Matter for Children with JIA (M3-JIA)
6. Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis (SMART-JIA)
7. Optimizing Treatment for Patients with Juvenile Idiopathic Arthritis in Sustained Remission: the MOVE-JIA Trial (MOVE-JIA)
8. Assessment of Macrophage Activation syndromE in STill's Disease (AMETHYST)
9. HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis
10. Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)
11. Efficiency of Supervised Exercise Program Versus Mobile-Based Exercise Program in Juvenile Idiopathic Arthritis
12. STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS (STARS)
13. A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy (GO-VIVA)
14. A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis (PSUMMIT-Jr)
15. An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) (SKYPP)
16. Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions
17. Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis
18. Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis. (SELECT-sJIA)
19. Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis (KRXeljanzJIA)
20. An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
21. Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity (RAISE)
22. Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical Remission (Re-JIA)
23. Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis (PEAPOD)
24. Pediatric Arthritis Study of Certolizumab Pegol (PASCAL)
25. A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
26. A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JUVE-X)
27. 30-Second Sit-to-Stand Test for Assessing Functional Capacity in Juvenile Idiopathic Arthritis
28. To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.
29. Effects of Telemonitoring-supported Game-based Home Exercises in Juvenile Idiopathic Arthritis
30. A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
31. Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
32. An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediatric Participants With Polyarticular Juvenile Idiopathic Arthritis (pJIA)
33. Cognitive Exercise Therapy Approach (BETY) in Childhood Rheumatic Diseases
34. A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
35. Transcutaneous Vagus Nerve Stimulation (tcVNS) in JIA (AJA01)
36. A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
37. A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)
38. UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease (UCAN CAN-DU)
39. Fitness Integrative Training for Pediatric Rheumatology Disorders (FIT Teens 2)
40. Core Stabilization Training in Juvenile Spondyloarthropathy
41. Angiogenic Biomarkers in Juvenile Idiopathic Arthritis (MAJIC)
42. Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis (PRECISE)
43. Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
44. Feasibility of a Diet Intervention for Juvenile Arthritis (DIGEST-JA)
45. SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis (VACOVAJI)
46. A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis (SELECT-YOUTH)
47. Clinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic Arthritis
48. The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis
49. Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis (Toddler)
50. Analysis of Peripheral Blood Lymphocytes in Patients With Juvenile Idiopathic Arthritis With Respect to Disease Subtypes and Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.